EW · Insider Trading

Edwards Lifesciences Corp

Iron condor setups Expected move IV rank history Fibonacci levels Insider trading

Every open-market purchase and sale reported by EW officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Form 4 Filings

most recent

Open-Market Buys

code P

Sales

code S

Reporting Insiders

current holders

EW — Recent Form 4 Transactions (latest 2026-10-08)

Filed	Insider	Role	Type	Shares	Value
2026-10-08	Daniel J. Lippis	CVP, TAVR	MIXED	—	−$8.03K
2026-09-14	Wayne Markowitz	CVP, JAPAC	F	−923	−$78.73K
2026-09-14	Andrew M. Dahl	SVP, Corporate Controller	F	−253	−$21.35K
2026-09-11	Daveen Chopra	CVP, TMTT, Surgical & IHFM	F	−398	−$34.53K
2026-09-11	Daniel J. Lippis	CVP, TAVR	MIXED	—	−$9.18K
2026-08-31	Andrew M. Dahl	SVP, Corporate Controller	Sell	−544	−$49.53K
2026-08-28	Annette Bruls	CVP, EMEACLA	Sell	−2,644	−$237.91K
2026-08-26	Wayne Markowitz	CVP, JAPAC	Sell	−1,240	−$113.42K
2026-08-26	Daveen Chopra	CVP, TMTT, Surgical & IHFM	MIXED	—	−$583.22K
2026-08-11	Daniel J. Lippis	CVP, TAVR	MIXED	—	−$11.98K
2026-07-30	Wayne Markowitz	CVP, JAPAC	Sell	−146	−$12.59K
2026-07-28	Wayne Markowitz	CVP, JAPAC	MIXED	—	−$106.29K
2026-07-27	Bernard J Zovighian	CEO	MIXED	−2,920	−$245.13K
2026-07-13	Annette Bruls	CVP, EMEACLA	F	−109	−$10.05K
2026-07-10	Daniel J. Lippis	CVP, TAVR	MIXED	—	−$11.77K
2026-07-10	Theodora Mistras	CVP, Chief Financial Officer	A	+99,920	—
2026-07-07	Daniel J. Lippis	CVP, TAVR	F	−377	−$35.88K
2026-06-17	Bernard J Zovighian	CEO	Sell	−523	−$45.98K
2026-05-29	Andrew M. Dahl	SVP, Corporate Controller	Sell	−567	−$48.85K
2026-05-27	Donald E Bobo Jr	CVP,Strategy/Corp Development	Sell	−23,145	−$2.00M
2026-05-22	Daveen Chopra	CVP, TMTT & Surgical	Sell	−1,500	−$126.91K
2026-05-18	Donald E Bobo Jr	CVP,Strategy/Corp Development	Sell	−17,968	−$1.47M
2026-05-18	Daniel J. Lippis	CVP, TAVR	MIXED	—	−$5.25K
2026-05-12	Daveen Chopra	CVP, TMTT & Surgical	MIXED	+6,045	−$602.74K
2026-05-12	Donald E Bobo Jr	CVP,Strategy/Corp Development	MIXED	+5,988	−$597.22K
2026-05-12	Bernard J Zovighian	CEO	MIXED	−15,342	−$4.93M
2026-05-11	Daniel J. Lippis	CVP, TAVR	F	−362	−$28.95K
2026-05-11	Bernard J Zovighian	CEO	MIXED	+34,249	−$792.27K
2026-05-11	Wayne Markowitz	CVP, JAPAC	MIXED	+4,117	−$87.95K
2026-05-11	Scott B. Ullem	CVP, Chief Financial Officer	MIXED	+8,826	−$879.88K
2026-05-08	Annette Bruls	CVP, EMEACLA	MIXED	+6,566	−$6.95K
2026-05-08	Daveen Chopra	CVP, TMTT & Surgical	MIXED	+7,860	−$150.51K
2026-05-08	Andrew M. Dahl	SVP, Corporate Controller	MIXED	+6,716	−$23.92K
2026-05-08	Daniel J. Lippis	CVP, TAVR	MIXED	+7,091	−$62.95K
2026-05-08	Leslie C. Davis	Director	A	+3,251	—
2026-05-08	Scott B. Ullem	CVP, Chief Financial Officer	F	−3,034	−$251.70K
2026-05-08	Donald E Bobo Jr	CVP,Strategy/Corp Development	MIXED	+5,981	−$155.04K
2026-05-08	David T Feinberg	Director	A	+3,251	—
2026-05-08	Kieran Gallahue	Director	A	+4,315	—
2026-05-08	Heisz Leslie Stone	Director	A	+3,251	—
2026-05-08	Paul A Laviolette	Director	A	+3,251	—
2026-05-08	Steven R Loranger	Director	A	+4,315	—
2026-05-08	Ramona Sequeira	Director	A	+3,251	—
2026-05-08	Nicholas J Valeriani	Director	A	+5,127	—
2026-05-05	Bernard J Zovighian	CEO	MIXED	−515	−$43.25K
2026-05-05	Scott B. Ullem	CVP, Chief Financial Officer	MIXED	+1,249	−$204.60K
2026-05-04	Donald E Bobo Jr	CVP,Strategy/Corp Development	F	−469	−$39.39K
2026-05-04	Daveen Chopra	CVP, TMTT & Surgical	F	−282	−$23.68K
2026-05-04	Daniel J. Lippis	CVP, TAVR	MIXED	−252	−$70.56K
2026-04-09	Scott B. Ullem	CVP, Chief Financial Officer	MIXED	—	−$270.21K

EW — Current Insider Holders

Insider	Role	Shares Held	Value
Scott B. Ullem	CVP, Chief Financial Officer	313,058	$27.96M
Larry L Wood	Global President TAVR & Surg	207,048	$18.49M
Donald E Bobo Jr	CVP,Strategy/Corp Development	121,409	$10.84M
Bernard J Zovighian	CEO	107,760	$9.62M
Theodora Mistras	CVP, Chief Financial Officer	87,595	$7.82M
Nicholas J Valeriani	Director	84,423	$7.54M
Steven R Loranger	Director	83,305	$7.44M
Kieran Gallahue	Director	82,907	$7.40M
Daveen Chopra	CVP, TMTT, Surgical & IHFM	43,926	$3.92M
Daniel J. Lippis	CVP, TAVR	40,652	$3.63M
Heisz Leslie Stone	Director	34,199	$3.05M
Ramona Sequeira	Director	20,855	$1.86M
Wayne Markowitz	CVP, JAPAC	19,938	$1.78M
Annette Bruls	CVP, EMEACLA	17,984	$1.61M
Paul A Laviolette	Director	17,552	$1.57M
Andrew M. Dahl	SVP, Corporate Controller	14,615	$1.31M
Leslie C. Davis	Director	9,834	$878.18K
David T Feinberg	Director	9,087	$811.47K

EW Insider Trading FAQ

Who are the insiders at EW?

18 officers, directors and 10%+ beneficial owners currently report holdings in EW via SEC Form 4.

Are EW insiders buying or selling?

Across the 50 most recent Form 4 filings for EW, 0 were open-market purchases (code P) and 9 were sales (code S). Sales frequently reflect scheduled 10b5-1 plans or tax withholding rather than a view on the stock.

How current is EW insider data?

Form 4 must be filed within two business days of the transaction, so this is close to real time. The most recent EW filing is dated 2026-10-08.

How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the EW quote page; the site-wide leaderboard is on the insider transactions hub.